tumour classification Flashcards

1
Q

outline the difference between the terms neoplasm and tumour

A

tumour = anything that causes an abnormal swelling, for example, inflammation, neoplasm, hypertrophy or hypotrophy

neoplasm = a localised abnormality from an abnormal growth of cells which persists after the initiating stimulus has been removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define neoplasm

A

A lesion (localised abnormality) resulting from the autonomous or relatively autonomous abnormal growth of cells which persists after the initiating stimulus has been removed.

  • it is persistent and no longer needs an initiating event to grow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the 2 main structural components of a neoplasm?

A
  • neoplastic cel
  • stroma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the 3 behavioural classifications of neoplasm?

A

Benign
Borderline
Malignant

however its pretty much a scale and not always a set catagory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the role of the neoplastic cell in a neoplasm?

A
  • known as the tumour cellswhich drives the neoplasms growth
  • Makes up the proliferating abnormal cells
  • Determines the biological behaviour and tumour type (e.g., carcinoma or sarcoma).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the role of the stroma in a neoplasm?

A
  • non-cancerous supportive tissue that surrounds and interacts with the neoplastic cells
  • Provides structural support and supplies nutrients, oxygen, and growth signals.
  • Includes connective tissue, blood vessels, and inflammatory cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what type of cells are neoplastic cells derived from and what determines their growth pattern?

A
  • Derive from nucleated cells
  • Usually monoclonal
  • Growth pattern and synthetic activity related to parent cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

which characteristics do we use to classify neoplasms?

A

Behavioural - Benign/Malignant
Histogenetic - Cell of origin
degree of classification - how much they resemble normal tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

outline the characteristics of malignant neoplasms?

A
  • Invasive
  • Metastases - process of cancer cells spreading from origin and invading
  • Rapid growth rate
  • Variable resemblance to normal tissue
  • Poorly defined or irregular border on histology slides compared to normal tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what microscopic structural characteristics do malignant neoplasms have?

A
  • Hyperchromatic nuclei
  • Pleomorphic nuclei (variation in size, shape and structure)
  • Increased mitotic activity
  • Necrosis and ulceration common
  • Growth on mucosal surfaces and skin often endophytic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

why are benign neoplasms still a potential cause for concern?

A
  • Pressure on adjacent structures
  • Obstruct flow
  • Produce hormones
  • Transform to malignant neoplasm
  • Anxiety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the characteristics of benign neoplasms?

A
  • Localised, non-invasive
  • Slow growth rate
  • Low mitotic activity
  • Close resemblance to normal tissue
  • Circumscribed or encapsulated
  • Nuclear morphometry often normal
  • Necrosis is rare
  • Ulceration is rare
  • Growth on mucosal surfaces usually exophytic (projecting outwards, eg moles)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

define histogenesis.

A

The specific cell of origin of a neoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

when would the term adenoma be used to describe a neoplasm?

A
  • Benign neoplasm of glandular or secretory epithelium
  • Prefix with cell type of origin, e.g. colonic adenoma, thyroid adenoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the 2 names to describe benign epithelial neoplasms?

A
  • adenoma
  • papilloma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when would the term papilloma be used to describe a neoplasm?

A
  • Benign neoplasm of non-glandular non-secretory epithelium
  • Prefix with cell type of origin, e.g. squamous cell papilloma
17
Q

what is the term given to malignant epithelial cancer?

A
  • carcinoma
18
Q

what is the term given to carcinomas of glandular epithelium?

A

adenocarcinomas

19
Q

what are the terms given to benign connective tissue neoplasms, adipocytes, cartilage, bone and vascular, striated muscle, smooth muscle and nerves and how would these names differ if the cancer was malignant?

A

Lipoma: adipocytes
Chondroma: cartilage
Osteoma: bone
Angioma: vascular
Rhabdomyoma: striated muscle
Leiomyoma: smooth muscle
Neuroma: nerves

if cancer was malignant it would have “sarcoma” instead of “oma”

20
Q

define anaplastic

A

Where cell type of origin cannot be determined, the neoplasm is said to be anaplastic

21
Q

exceptions to the rule

A
  • Not all ‘-omas’ are neoplasms
    e.g. granuloma, mycetoma, tuberculoma
  • Not all malignant neoplasms are carcinomas or sarcomas, e.g.:
    Melanoma: malignant neoplasm of melanocytes
    Mesothelioma: malignant neoplasm of mesothelial cells
    Lymphoma: malignant neoplasm of lymphoid cells
  • some neoplasms are named after someone eg burkitt lymphoma
  • embryonal neoplasms
  • mixed neoplasms
22
Q

Define the incidence of neoplastic disease.

A

The incidence of neoplastic disease refers to the number of new cases of neoplasms (tumors, which can be benign or malignant) diagnosed in a specific population over a defined period, typically expressed as a rate per 100,000 individuals per year.

For example:

“The incidence of breast cancer in a given region may be 125 cases per 100,000 women per year.”
Incidence helps measure the risk of developing neoplastic diseases and is often used in epidemiological studies to track trends and allocate healthcare resources.